Dongzhe Hong on Biosimilar Uptake in the US
Aug 27, 2024•23 min•Ep. 189
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Subscribe to UnitedHealthcare's Community & State newsletter.
Health Affairs' Editor-in-Chief Alan Weil interviews Dongzhe Hong of Brigham and Women’s Hospital and Harvard University on his recent paper that explores how patient and prescriber factors play into biosimilar uptake in the US.
Order the August 2024 issue of Health Affairs.
Currently, more than 70 percent of our content is freely available - and we'd like to keep it that way. With your support, we can continue to keep our digital publication Forefront and podcasts free for everyone.
Subscribe to UnitedHealthcare's Community & State newsletter.
For the best experience, listen in Metacast app for iOS or Android